Unichem Laboratories Limited

NSE UNICHEMLAB.NS

Unichem Laboratories Limited Revenue Per Share for the year ending March 31, 2024: USD 2.82

Unichem Laboratories Limited Revenue Per Share is USD 2.82 for the year ending March 31, 2024, a 21.58% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Unichem Laboratories Limited Revenue Per Share for the year ending March 31, 2023 was USD 2.32, a -0.58% change year over year.
Unichem Laboratories Limited Revenue Per Share for the year ending March 31, 2022 was USD 2.33, a 1.14% change year over year.
Unichem Laboratories Limited Revenue Per Share for the year ending March 31, 2021 was USD 2.31, a 5.89% change year over year.
Unichem Laboratories Limited Revenue Per Share for the year ending March 31, 2020 was USD 2.18, a -5.01% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

NSE: UNICHEMLAB.NS

Unichem Laboratories Limited

CEO	Mr. Scott B. Delaney
IPO Date	July 1, 2002
Location	India
Headquarters	Unichem Bhavan
Employees	2,875
Sector	Health Care
Industries Pharmaceuticals

Description

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.

Key trends

Past 5 years